Overview

Coronavirus Response - Active Support for Hospitalised Covid-19 Patients

Status:
Withdrawn
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The CRASH-19 trial is a multinational, open-label, factorial, randomised trial in adults hospitalised with suspected or confirmed acute COVID-19 infection.
Phase:
Phase 3
Details
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Treatments:
Aspirin
Losartan
Simvastatin